Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
Clinical trial NCT04442269 · COMPLETED
Trial details
- NCT number
- NCT04442269
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2023-07-27
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.